Cannabis Science Inc (fka CBIS)

[platero]

Look for an update on one or more of CBIS development paths and revenue ops this month BEFORE the dividend date:

Cannabis Science will be providing guidance on its key areas of future business development with primary focus on:

Investigative New Drug Applications to the FDA for critical ailments.

Over the Counter Medicines

Laboratory for formulation applications, testing and FDA trials.

Current progress on its Rockbrook Inc. Commercialization Agreement

Strategic partnerships, acquisitions and joint ventures.

Establish Cannabis Science clinics and hospitals for patient treatment.

New cannabis formulations and discoveries for research and development.